Establishment of a novel radioligand assay using eukaryotically expressed cytchrome P4502D6 for the measurement of liver kidney microsomal type 1 antibdy in patients with autoimmune hepatitis and hepatitis C virus infection
- 31 July 1997
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 26 (6), 1396-1402
- https://doi.org/10.1016/s0168-8278(97)80477-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.The Journal of Immunology, 1996
- Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligandsJournal of Immunological Methods, 1995
- Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infectionClinical and Experimental Immunology, 1994
- Meeting report: International autoimmune hepatitis groupHepatology, 1993
- Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative seraGastroenterology, 1993
- Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti‐liver‐kidney microsome type‐1 antibodies (LKM1)European Journal of Immunology, 1993
- Type 2 autoimmune hepatitis and hepatitis C virus infectionThe Lancet, 1990
- Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.Journal of Clinical Investigation, 1989
- Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitisHepatology, 1987
- Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum.The Journal of Experimental Medicine, 1985